Grant Pickering - Aug 23, 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
/s/ Ron Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Aug 23, 2021
Transactions value $
-$286,254
Form type
4
Date filed
8/25/2021, 06:11 PM
Previous filing
Aug 20, 2021
Next filing
Sep 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $24.5K +13.7K +2.36% $1.79 594K Aug 23, 2021 Direct
transaction PCVX Common Stock Sale -$309K -13.6K -2.29% $22.73 580K Aug 23, 2021 Direct F1, F2
transaction PCVX Common Stock Sale -$1.59K -69 -0.01% $23.10 580K Aug 23, 2021 Direct F1
holding PCVX Common Stock 356K Aug 23, 2021 By Children's Trusts

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -13.7K -3.53% $0.00 374K Aug 23, 2021 Common Stock 13.7K $1.79 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $22.00 to $22.985. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 The shares subject to the option are fully vested and exercisable.